Company
Aion Therapeutic Inc.
CNSX:AION
Aion Therapeutic Inc. is an emerging unique international pharmaceutical company specializing in joining together the healing powers of medical cannabis and medicinal mushroom compounds creating a new class of therapeutics which it believes will lead to a paradigm shift in healthcare globally. Its subsidiary AI Pharmaceuticals Jamaica Limited develops formulations and products that utilize mushrooms — functional and ones including psilocybin — fungi, and other natural formulations from medicinal plants in a legal environment.
7 stories
Aion Therapeutic announces intellectual property sale to Apollon Formularies
The company said this repositioning of its assets will provide for a more streamlined approach to the commercialization of functional wellness-based products and treatments
Aion Therapeutic brings in over C$1.4M after closing private placing
The pharma-focused group issued over 16.9 million units at C$0.0875 each
Aion says its medicinal mushroom and cannabis formulations made with Apollon effective at killing breast cancer cells
AION F7 and AION F8 may be effective in treating multiple breast cancer types, including the notoriously difficult to treat triple-negative breast cancer
Aion Therapeutic says studies show medicinal mushroom preparations highly effective at killing breast cancer cells
In a series of recent third-party independent studies, the preparations demonstrated direct killing of HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and triple-negative breast cancer cells
Aion Therapeutic files new patent applications for using medicinal mushrooms to treat breast and other cancers
The patent applications also concern the use of combining medical cannabis and medicinal mushroom preparations for the treatment of interstitial cystitis and other bladder diseases